title: Opioid and dopamine antagonist drug challenges in untreated restless legs syndrome patients.
abstract: Background: The restless legs syndrome (RLS) is a common sensomotor disorder associated with severe sleep disturbances. Symptoms clearly improve following treatment with dopaminergic or opioidergic agonists.Objective: To further elucidate the involvement of opioidergic and dopaminergic mechanisms in the pathophysiology of RLS, the effects of specific antagonists on motor (periodic leg movements) and subjective (sensory) RLS-symptoms during daytime were assessed.Methods: A modified suggested immobilization test was performed in eight drug-naive RLS-patients. An infusion of either naloxone, metoclopramide or placebo was administered. In addition, the hormonal levels of adrenocorticotropic hormone, cortisol, prolactin and growth hormone were determined, to elucidate a possible involvement of the hypothalamic-pituitary-adrenocortical (HPA) system in RLS.Results: RLS sensory or motor symptoms could not be provoked. Hormonal responses showed no abnormal profiles.Conclusions: Rather than a general alteration of the opioidergic/dopaminergic tone and an involvement of the HPA system, it is more likely that specific neuronal dopaminergic or opioidergic pathways are altered in the pathophysiology of RLS.
authors.affiliation: Section of Neurology, Max Planck Institute of Psychiatry, Kraepelinstrasse 10, 80804, Munich, Germany
authors.initials: J
authors.lastname: Winkelmann
authors.initials: J
authors.lastname: Schadrack
authors.initials: TC
authors.lastname: Wetter
authors.initials: W
authors.lastname: Zieglgänsberger
authors.initials: C
authors.lastname: Trenkwalder